1. Malmstrom S, Wagner P, Yilmaz A, Svedhem V, et al.
   Failure to restore CD4 count associated with infection-related and non-infection-related cancer.
   AIDS 2021.
   


2. El-Nahal WG, Shen NM, Keruly JC, Jones JL, et al.
   Telemedicine and visit completion among people with HIV during the COVID-19 pandemic compared to pre-pandemic.
   AIDS 2021.
   


3. Becasen JS, Morris JD, Denard CL, Mullins MM, et al.
   HIV care outcomes among transgender persons with HIV infection in the united states: a systematic review and meta-analysis, 2006-2021.
   AIDS 2021.
   


4. Fursa O, Mocroft A, Lazarus JV, Amele S, et al.
   The hepatitis C cascade of care in HIV/HCV-coinfected individuals in Europe- regional and intra-regional differences.
   AIDS 2021.
   


5. Quinn JR, Goyal A, Ribeiro RM, Massaccesi G, et al.
   Antiretroviral therapy for HIV and intrahepatic hepatitis C virus replication.
   AIDS 2021.
   


6. Cedarbaum ER, Ma Y, Adimora AA, Bamman M, et al.
   Peripheral artery disease and physical function in women with and without HIV.
   AIDS 2021.
   


7. Madyadi A, Dhoro M, Shamu T, Washaya T, et al.
   HIV-1 genetic diversity and natural polymorphisms of the integrase gene in integrase inhibitor naive patients in Harare, Zimbabwe.
   AIDS Res Hum Retroviruses 2021.
   


8. Furler RL, Nixon DF.
   HIV-1 Exploits Transitions Between CD4+ T Cell Migration and Activation.
   AIDS Res Hum Retroviruses 2021.
   


9. Brouillette MJ, Koski L, Scott S, Austin-Keiller A, et al.
   Factors influencing psychological distress during the COVID-19 pandemic in people aging with HIV.
   AIDS Res Hum Retroviruses 2021.
   


10. Hiransuthikul A, Chutinet A, Sophonphan J, Ubolyam S, et al.
    Incidence and risk factors of ischemic stroke and transient ischemic attack among people living with HIV: a longitudinal cohort study.
    AIDS Res Hum Retroviruses 2021.
    


11. Wallner J, Beck IA, Panpradist N, Ruth PS, et al.
    Rapid, Near Point-of-Care Assay for HLA-B*57:01 Genotype Associated with Severe Hypersensitivity Reaction to Abacavir.
    AIDS Res Hum Retroviruses 2021.
    


12. Laher F, Richardson SI, Smith P, Sullivan P, et al.
    HIV prevention in a time of COVID-19: A report from the HIVR4P // Virtual conference 2021.
    AIDS Res Hum Retroviruses 2021.
    


13. Galaviz KI, Shah S, Gutierrez M, Collins LF, et al.
    Patient Experiences with Telemedicine for HIV Care during the first COVID-19 Wave in Atlanta, Georgia.
    AIDS Res Hum Retroviruses 2021.
    


14. Gulick RM, Glesby MJ.
    Managing HIV Treatment Failure: Time to REVAMP?
    Ann Intern Med 2021.
    


15. Siedner MJ, Moosa MS, McCluskey S, Gilbert RF, et al.
    Resistance Testing for Management of HIV Virologic Failure in Sub-Saharan Africa : An Unblinded Randomized Controlled Trial.
    Ann Intern Med 2021.
    


16. Khalili M, King WC, Kleiner DE, Chung RT, et al.
    Evolution of Fatty Liver Disease and Relationship With Lipoproteins and Clinical Outcomes in Hepatitis B/Human Immunodeficiency Virus Coinfection.
    Clin Infect Dis 2021.
    


17. Harney BL, Sacks-Davis R, van Santen DK, Traeger M, et al.
    The Incidence of Hepatitis C Among Gay, Bisexual, and Other Men Who Have Sex With Men in Australia, 2009-2019.
    Clin Infect Dis 2021.
    


18. Ramirez PC, Diaz-Quijano FA.
    Using a Composite Outcome in Estimating the Effect of Co-trimoxazole Prophylaxis on Prognosis in African Adults Receiving Antiretroviral Therapy.
    Clin Infect Dis 2021;73:1550-1551.
    


19. Bates L, Honeycutt A, Bass S, Green TA, et al.
    Updated Estimates of the Number of Men Who Have Sex With Men (MSM) With Indications for HIV Pre-exposure Prophylaxis.
    J Acquir Immune Defic Syndr 2021;88:e28-e30.
    


20. Koay WLA, Prabhakar S, Neilan A, Meyers J, et al.
    Brief Report: Supporting Access to HIV Care for Children and Youth During the COVID-19 Pandemic With Telemedicine and Rideshare.
    J Acquir Immune Defic Syndr 2021;88:384-388.
    


21. Rees H, Chersich MF, Munthali RJ, Brumskine W, et al.
    HIV Incidence Among Pregnant and Nonpregnant Women in the FACTS-001 Trial: Implications for HIV Prevention, Especially PrEP Use.
    J Acquir Immune Defic Syndr 2021;88:376-383.
    


22. Shaffer D, Kumwenda J, Chen H, Akelo V, et al.
    Brief Report: No Differences Between Lopinavir/ritonavir and non-Nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy on Clearance of Plasmodium falciparum Subclinical Parasitemia in Adults Living With HIV Starting Treatment (A5297)
    J Acquir Immune Defic Syndr 2021.
    


23. Rousseau RK, Walmsley SL, Lee T, Rosenes R, et al.
    A randomized, blinded, placebo-controlled trial of De Simone formulation probiotic during HIV-associated suboptimal CD4+ T cell recovery.
    J Acquir Immune Defic Syndr 2021.
    


24. Sahagun SJ, Yeramosu T, Purdy JB, Reynolds JC, et al.
    Associations between Central Obesity and Life-Long Antiviral Therapy in Adults Living with HIV Acquired from Early Childhood.
    J Acquir Immune Defic Syndr 2021.
    


25. Nanyonga SM, Kitutu FE, Kalyango J, Frank M, et al.
    High burden of adverse drug reactions to Isoniazid Preventive Therapy in people living with HIV at three tertiary hospitals in Uganda: associated factors.
    J Acquir Immune Defic Syndr 2021.
    


26. Abolhassani H, Vosughimotlagh A, Asano T, Landegren N, et al.
    X-Linked TLR7 Deficiency Underlies Critical COVID-19 Pneumonia in a Male Patient with Ataxia-Telangiectasia.
    J Clin Immunol 2021.
    


27. Li M, Garforth SJ, O'Connor KE, Su H, et al.
    T-cell receptor-specific immunotherapeutics drive selective in vivo HIV and CMV-specific T-cell expansion in humanized mice.
    J Clin Invest 2021.
    


28. Peluso MJ, Lu S, Tang AF, Durstenfeld MS, et al.
    Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    J Infect Dis 2021.
    


29. Chavan VR, Ahir S, Kerkar S, Ansari Z, et al.
    Th1 cytokine gene polymorphism and the corresponding plasma cytokine levels: A comparative study in HIV-1 positive and exposed uninfected infants.
    J Med Virol 2021.
    


30. Yu J, Collins ND, Mercado NB, McMahan K, et al.
    Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery Against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques.
    J Virol 2021.
    


31. Hotzel I.
    Domain Organization of Lentiviral and Betaretroviral Surface Envelope Glycoproteins Modeled with AlphaFold.
    J Virol 2021.
    


32. Blazkova J, Gao F, Marichannegowda MH, Justement JS, et al.
    Distinct mechanisms of long-term virologic control in two HIV-infected individuals after treatment interruption of anti-retroviral therapy.
    Nat Med 2021.
    


33. Bayer R, Oppenheimer GM, Parisi V.
    Marking the 40th Anniversary of the AIDS Epidemic - American Physicians Look Back.
    N Engl J Med 2021;385:1251-1253.
    


34. Li SNJ, Albert A, Piske M, Janssen PA, et al.
    Higher Hospitalization Rates in Children Born HIV-exposed Uninfected in British Columbia, Canada, Between 1990 and 2012.
    Pediatr Infect Dis J 2021.
    


35. Wilkinson E, Giovanetti M, Tegally H, San JE, et al.
    A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa.
    Science 2021;374:423-431.
    

Display articles in

• Abstract format
• Medline format